{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:39:34Z","timestamp":1792600774946,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s11060-026-05843-6","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:48:54Z","timestamp":1792597734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neighborhood material deprivation and days at home after glioblastoma diagnosis"],"prefix":"10.1007","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3389-3101","authenticated-orcid":false,"given":"Jasleen","family":"Saini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwathsen","family":"Karthikeyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husain","family":"Shakil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armaan K.","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingshi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jane","family":"Lim-Fat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jetan","family":"Badhiwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefferson R.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saira B.","family":"Alli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"5843_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"5843_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/nejmoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/nejmoa043330","journal-title":"N Engl J Med"},{"key":"5843_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","volume":"18","author":"M Weller","year":"2021","unstructured":"Weller M, van den Bent M, Preusser M et al (2021) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 18:170\u2013186. https:\/\/doi.org\/10.1038\/s41571-020-00447-z. Published correction: Nat Rev Clin Oncol (2022) 19:357\u2013358. https:\/\/doi.org\/10.1038\/s41571-022-00623-3","journal-title":"Nat Rev Clin Oncol"},{"key":"5843_CR4","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","volume":"22","author":"PY Wen","year":"2020","unstructured":"Wen PY, Weller M, Lee EQ et al (2020) Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol 22:1073\u20131113. https:\/\/doi.org\/10.1093\/neuonc\/noaa106","journal-title":"Neuro Oncol"},{"key":"5843_CR5","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/nejmoa1611977","volume":"376","author":"JR Perry","year":"2017","unstructured":"Perry JR, Laperriere N, O\u2019Callaghan CJ et al (2017) Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma. N Engl J Med 376:1027\u20131037. https:\/\/doi.org\/10.1056\/nejmoa1611977","journal-title":"N Engl J Med"},{"key":"5843_CR6","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp R, Taillibert S, Kanner A et al (2017) Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial. JAMA 318:2306\u20132316. https:\/\/doi.org\/10.1001\/jama.2017.18718. Published correction: JAMA (2018) 319:1824. https:\/\/doi.org\/10.1001\/jama.2018.3431","journal-title":"JAMA"},{"key":"5843_CR7","doi-asserted-by":"publisher","first-page":"123821","DOI":"10.1016\/j.wneu.2025.123821","volume":"196","author":"S Taslimi","year":"2025","unstructured":"Taslimi S, Brogly S, Hanna TP, Shellenberger J, Whitehead M, Alkins R (2025) A Population-Based Cohort Study of Glioblastoma (World Health Organization Grade 4 Gliomas) in Ontario: Continued Improvement in Care over 25 Years. World Neurosurg 196:123821. https:\/\/doi.org\/10.1016\/j.wneu.2025.123821","journal-title":"World Neurosurg"},{"key":"5843_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/aln.0000000000002701","volume":"131","author":"A Jerath","year":"2019","unstructured":"Jerath A, Austin PC, Wijeysundera DN (2019) Days Alive and Out of Hospital: Validation of a Patient-centered Outcome for Perioperative Medicine. Anesthesiology 131:84\u201393. https:\/\/doi.org\/10.1097\/aln.0000000000002701","journal-title":"Anesthesiology"},{"key":"5843_CR9","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1002\/cncr.33817","volume":"127","author":"MB Lam","year":"2021","unstructured":"Lam MB, Riley KE, Zheng J, Orav EJ, Jha AK, Burke LG (2021) Healthy days at home: A population-based quality measure for cancer patients at the end of life. Cancer 127:4249\u20134257. https:\/\/doi.org\/10.1002\/cncr.33817","journal-title":"Cancer"},{"key":"5843_CR10","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1136\/bmjqs-2021-013150","volume":"32","author":"DI McIsaac","year":"2023","unstructured":"McIsaac DI, Talarico R, Jerath A, Wijeysundera DN (2023) Days alive and at home after hip fracture: a cross-sectional validation of a patient-centred outcome measure using routinely collected data. BMJ Qual Saf 32:546\u2013556. https:\/\/doi.org\/10.1136\/bmjqs-2021-013150","journal-title":"BMJ Qual Saf"},{"key":"5843_CR11","doi-asserted-by":"publisher","first-page":"e209904","DOI":"10.1212\/wnl.0000000000209904","volume":"103","author":"AK Malhotra","year":"2024","unstructured":"Malhotra AK, Nathens AB, Shakil H et al (2024) Days at Home After Traumatic Brain Injury: Moving Beyond Mortality to Evaluate Patient-Centered Outcomes Using Population Health Data. Neurology 103:e209904. https:\/\/doi.org\/10.1212\/wnl.0000000000209904","journal-title":"Neurology"},{"key":"5843_CR12","doi-asserted-by":"publisher","first-page":"znae278","DOI":"10.1093\/bjs\/znae278","volume":"111","author":"T Ribeiro","year":"2024","unstructured":"Ribeiro T, Malhotra AK, Bondzi-Simpson A et al (2024) Days at home after surgery as a perioperative outcome: scoping review and recommendations for use in health services research. Br J Surg 111:znae278. https:\/\/doi.org\/10.1093\/bjs\/znae278","journal-title":"Br J Surg"},{"key":"5843_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00520-026-10355-0","volume":"34","author":"T Ribeiro","year":"2026","unstructured":"Ribeiro T, Bondzi-Simpson A, Mahar A et al (2026) A novel patient-centered outcome in cancer care, days at home: a scoping review and guide for its future use. Support Care Cancer 34:131. https:\/\/doi.org\/10.1007\/s00520-026-10355-0","journal-title":"Support Care Cancer"},{"key":"5843_CR14","doi-asserted-by":"publisher","first-page":"e213742","DOI":"10.1212\/wnl.0000000000213742","volume":"105","author":"AT Omar","year":"2025","unstructured":"Omar AT, Diestro JDB, Aghanya V, Dare AJ, Spears J, Gomez D (2025) Cancer Health Disparities Affecting Glioblastoma Survival in Ontario, Canada: A Population-Based Study. Neurology 105:e213742. https:\/\/doi.org\/10.1212\/wnl.0000000000213742","journal-title":"Neurology"},{"key":"5843_CR15","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1093\/neuonc\/noy102","volume":"20","author":"DA Brown","year":"2018","unstructured":"Brown DA, Himes BT, Kerezoudis P et al (2018) Insurance correlates with improved access to care and outcome among glioblastoma patients. Neuro Oncol 20:1374\u20131382. https:\/\/doi.org\/10.1093\/neuonc\/noy102","journal-title":"Neuro Oncol"},{"key":"5843_CR16","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1002\/cncr.30160","volume":"122","author":"X Rong","year":"2016","unstructured":"Rong X, Yang W, Garzon-Muvdi T et al (2016) Influence of insurance status on survival of adults with glioblastoma multiforme: A population-based study. Cancer 122:3157\u20133165. https:\/\/doi.org\/10.1002\/cncr.30160","journal-title":"Cancer"},{"key":"5843_CR17","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1002\/cncr.32328","volume":"125","author":"DJ Cote","year":"2019","unstructured":"Cote DJ, Ostrom QT, Gittleman H et al (2019) Glioma incidence and survival variations by county-level socioeconomic measures. Cancer 125:3390\u20133400. https:\/\/doi.org\/10.1002\/cncr.32328","journal-title":"Cancer"},{"key":"5843_CR18","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1200\/jco.1997.15.4.1680","volume":"15","author":"WJ Mackillop","year":"1997","unstructured":"Mackillop WJ, Zhang-Salomons J, Groome PA, Paszat L, Holowaty E (1997) Socioeconomic status and cancer survival in Ontario. J Clin Oncol 15:1680\u20131689. https:\/\/doi.org\/10.1200\/jco.1997.15.4.1680","journal-title":"J Clin Oncol"},{"key":"5843_CR19","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.23889\/ijpds.v4i2.1135","volume":"4","author":"MJ Schull","year":"2020","unstructured":"Schull MJ, Azimaee M, Marra M et al (2020) ICES: Data, Discovery, Better Health. Int J Popul Data Sci 4:1135. https:\/\/doi.org\/10.23889\/ijpds.v4i2.1135","journal-title":"Int J Popul Data Sci"},{"key":"5843_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, STROBE Initiative (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61:344\u2013349. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008","journal-title":"J Clin Epidemiol"},{"key":"5843_CR21","doi-asserted-by":"publisher","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","volume":"12","author":"EI Benchimol","year":"2015","unstructured":"Benchimol EI, Smeeth L, Guttmann A et al (2015) The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med 12:e1001885. https:\/\/doi.org\/10.1371\/journal.pmed.1001885","journal-title":"PLoS Med"},{"key":"5843_CR22","unstructured":"Fritz A, Percy C, Jack A et al (eds) (2000) International Classification of Diseases for Oncology, 3rd edn. World Health Organization"},{"key":"5843_CR23","unstructured":"Matheson FI, Moloney G, van Ingen T (2023) 2021 Ontario marginalization index: user guide. st. michael\u2019s hospital (Unity Health Toronto); Public Health Ontario. https:\/\/www.publichealthontario.ca\/-\/media\/documents\/o\/2017\/on-marg-userguide.pdf. Accessed 13 September 2026"},{"key":"5843_CR24","doi-asserted-by":"publisher","first-page":"260","DOI":"10.17269\/s41997-021-00552-1","volume":"113","author":"T van Ingen","year":"2022","unstructured":"van Ingen T, Matheson FI (2022) The 2011 and 2016 iterations of the Ontario Marginalization Index: updates, consistency and a cross-sectional study of health outcome associations. Can J Public Health 113:260\u2013271. https:\/\/doi.org\/10.17269\/s41997-021-00552-1","journal-title":"Can J Public Health"},{"key":"5843_CR25","unstructured":"Hern\u00e1n MA, Robins JM (2020) Causal Inference: what if. Chapman & Hall\/CRC"},{"key":"5843_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","volume":"34","author":"TJ VanderWeele","year":"2019","unstructured":"VanderWeele TJ (2019) Principles of confounder selection. Eur J Epidemiol 34:211\u2013219. https:\/\/doi.org\/10.1007\/s10654-019-00494-6","journal-title":"Eur J Epidemiol"},{"key":"5843_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00001648-199901000-00005","volume":"10","author":"S Greenland","year":"1999","unstructured":"Greenland S, Pearl J, Robins JM (1999) Causal diagrams for epidemiologic research. Epidemiology 10:37\u201348. https:\/\/doi.org\/10.1097\/00001648-199901000-00005","journal-title":"Epidemiology"},{"issue":"suppl 3","key":"5843_CR28","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1093\/neuonc\/noab200","volume":"23","author":"QT Ostrom","year":"2021","unstructured":"Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2021) CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014\u20132018. Neuro Oncol 23(suppl 3):iii1\u2013iii105. https:\/\/doi.org\/10.1093\/neuonc\/noab200","journal-title":"Neuro Oncol"},{"key":"5843_CR29","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/neuonc\/noy002","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Rubin JB, Lathia JD, Berens ME, Barnholtz-Sloan JS (2018) Females have the survival advantage in glioblastoma. Neuro Oncol 20:576\u2013577. https:\/\/doi.org\/10.1093\/neuonc\/noy002","journal-title":"Neuro Oncol"},{"key":"5843_CR30","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/neuonc\/nou060","volume":"16","author":"ND Arvold","year":"2014","unstructured":"Arvold ND, Wang Y, Zigler C, Schrag D, Dominici F (2014) Hospitalization burden and survival among older glioblastoma patients. Neuro Oncol 16:1530\u20131540. https:\/\/doi.org\/10.1093\/neuonc\/nou060","journal-title":"Neuro Oncol"},{"key":"5843_CR31","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.wneu.2015.12.096","volume":"89","author":"M Cloney","year":"2016","unstructured":"Cloney M, D\u2019Amico R, Lebovic J et al (2016) Frailty in geriatric glioblastoma patients: a predictor of operative morbidity and outcome. World Neurosurg 89:362\u2013367. https:\/\/doi.org\/10.1016\/j.wneu.2015.12.096","journal-title":"World Neurosurg"},{"key":"5843_CR32","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1093\/neuonc\/noaf043","volume":"27","author":"Y Ellenbogen","year":"2025","unstructured":"Ellenbogen Y, Taslimi S, Shellenberger J, Brogly SB, Zadeh G, Alkins R (2025) End-of-life care in glioblastoma: a population-based study. Neuro Oncol 27:1640\u20131653. https:\/\/doi.org\/10.1093\/neuonc\/noaf043","journal-title":"Neuro Oncol"},{"key":"5843_CR33","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130\u20131139. https:\/\/doi.org\/10.1097\/01.mlr.0000182534.19832.83","journal-title":"Med Care"},{"key":"5843_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","volume":"36","author":"A Elixhauser","year":"1998","unstructured":"Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36:8\u201327. https:\/\/doi.org\/10.1097\/00005650-199801000-00004","journal-title":"Med Care"},{"key":"5843_CR35","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/mlr.0b013e31819432e5","volume":"47","author":"C van Walraven","year":"2009","unstructured":"van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ (2009) A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 47:626\u2013633. https:\/\/doi.org\/10.1097\/mlr.0b013e31819432e5","journal-title":"Med Care"},{"key":"5843_CR36","first-page":"e392","volume":"18","author":"SA Sternberg","year":"2012","unstructured":"Sternberg SA, Bentur N, Abrams C et al (2012) Identifying frail older people using predictive modeling. Am J Manag Care 18:e392\u2013e397","journal-title":"Am J Manag Care"},{"key":"5843_CR37","unstructured":"Kralj B (2009) Measuring rurality - RIO2008_BASIC: methodology and results. Ontario Medical Association Economics Department. https:\/\/www.oma.org\/siteassets\/oma\/media\/pagetree\/about-oma\/expert--advice\/2008rio-fulltechnicalpaper.pdf"},{"key":"5843_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1257\/jep.15.4.143","volume":"15","author":"R Koenker","year":"2001","unstructured":"Koenker R, Hallock KF (2001) Quantile Regression. J Econ Perspect 15:143\u2013156. https:\/\/doi.org\/10.1257\/jep.15.4.143","journal-title":"J Econ Perspect"},{"key":"5843_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2307\/1913643","volume":"46","author":"R Koenker","year":"1978","unstructured":"Koenker R, Bassett G Jr (1978) Regression Quantiles. Econometrica 46:33\u201350. https:\/\/doi.org\/10.2307\/1913643","journal-title":"Econometrica"},{"key":"5843_CR40","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch PM, Therneau TM (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515\u2013526. https:\/\/doi.org\/10.1093\/biomet\/81.3.515. Published correction: Biometrika (1995) 82:668. https:\/\/doi.org\/10.1093\/biomet\/82.3.668","journal-title":"Biometrika"},{"key":"5843_CR41","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1245\/s10434-024-16709-4","volume":"32","author":"OP Chatzipanagiotou","year":"2025","unstructured":"Chatzipanagiotou OP, Khalil M, Woldesenbet S, Catalano G, Pawlik TM (2025) Days at Home After Cancer Surgery: Impact of Area Deprivation and Association with Long-Term Outcomes. Ann Surg Oncol 32:2393\u20132402. https:\/\/doi.org\/10.1245\/s10434-024-16709-4","journal-title":"Ann Surg Oncol"},{"key":"5843_CR42","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.trecan.2023.01.006","volume":"9","author":"WV Johnson","year":"2023","unstructured":"Johnson WV, Blaes AH, Booth CM, Ganguli I, Gupta A (2023) The unequal burden of time toxicity. Trends Cancer 9:373\u2013375. https:\/\/doi.org\/10.1016\/j.trecan.2023.01.006","journal-title":"Trends Cancer"},{"key":"5843_CR43","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1200\/jco.21.02810","volume":"40","author":"A Gupta","year":"2022","unstructured":"Gupta A, Eisenhauer EA, Booth CM (2022) The Time Toxicity of Cancer Treatment. J Clin Oncol 40:1611\u20131615. https:\/\/doi.org\/10.1200\/jco.21.02810","journal-title":"J Clin Oncol"},{"key":"5843_CR44","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11060-018-2800-1","volume":"138","author":"M Seibl-Leven","year":"2018","unstructured":"Seibl-Leven M, von Reeken C, Goldbrunner R et al (2018) Clinical routine assessment of palliative care symptoms and concerns and caregiver burden in glioblastoma patients: an explorative field study. J Neurooncol 138:321\u2013333. https:\/\/doi.org\/10.1007\/s11060-018-2800-1","journal-title":"J Neurooncol"},{"key":"5843_CR45","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/nejmoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi ME, Diserens AC, Gorlia T et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997\u20131003. https:\/\/doi.org\/10.1056\/nejmoa043331","journal-title":"N Engl J Med"},{"key":"5843_CR46","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1177\/02692163231152526","volume":"37","author":"LT Shieh","year":"2023","unstructured":"Shieh LT, Ho CH, Guo HR, Ho YC, Ho SY (2023) Comparison of healthcare utilization and life-sustaining interventions between patients with glioblastoma receiving palliative care or not: a population-based study. Palliat Med 37:824\u2013833. https:\/\/doi.org\/10.1177\/02692163231152526","journal-title":"Palliat Med"},{"key":"5843_CR47","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/neuonc\/noaf230","volume":"28","author":"H Golla","year":"2026","unstructured":"Golla H, Nettekoven C, Hellmich M et al (2026) Early palliative care for patients with glioblastoma: a randomized phase III clinical trial (EPCOG). Neuro Oncol 28:226\u2013240. https:\/\/doi.org\/10.1093\/neuonc\/noaf230","journal-title":"Neuro Oncol"},{"key":"5843_CR48","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10654-016-0149-3","volume":"31","author":"S Greenland","year":"2016","unstructured":"Greenland S, Senn SJ, Rothman KJ et al (2016) Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. Eur J Epidemiol 31:337\u2013350. https:\/\/doi.org\/10.1007\/s10654-016-0149-3","journal-title":"Eur J Epidemiol"},{"key":"5843_CR49","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/ije\/dyp334","volume":"39","author":"SR Cole","year":"2010","unstructured":"Cole SR, Platt RW, Schisterman EF et al (2010) Illustrating bias due to conditioning on a collider. Int J Epidemiol 39:417\u2013420. https:\/\/doi.org\/10.1093\/ije\/dyp334","journal-title":"Int J Epidemiol"},{"key":"5843_CR50","doi-asserted-by":"publisher","first-page":"h4773","DOI":"10.1136\/bmj.h4773","volume":"351","author":"P Sedgwick","year":"2015","unstructured":"Sedgwick P (2015) Understanding the ecological fallacy. BMJ 351:h4773. https:\/\/doi.org\/10.1136\/bmj.h4773. Published correction: BMJ (2018) 362:k4129. https:\/\/doi.org\/10.1136\/bmj.k4129","journal-title":"BMJ"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05843-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05843-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05843-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:48:56Z","timestamp":1792597736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05843-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["5843"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05843-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"18 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Unity Health Toronto Research Ethics Board approved the study (approval no. 21\u2013145). The study was conducted in accordance with the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS 2). Data use was authorized under Sect.\u00a0 45 of Ontario\u2019s Personal Health Information Protection Act.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Individual consent was waived for use of deidentified administrative data.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.","order":3,"name":"Ethics","label":"Role of the funder","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"J.S. had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.","order":4,"name":"Ethics","label":"Data access and responsibility","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28"}}